Effects of anti-inflammatory [1, 2, 4]triazolo[4, 3-a] [1, 8]naphthyridine derivatives on human stimulated PMN and endothelial cells: An in vitro study

Journal of Inflammation

Volumn 3, Issue , 2006, Pages

  Dianzani, Chiara ^a   Collino, Massimo ^a   Gallicchio, Margherita ^a   Di Braccio, Mario ^b   Roma, Giorgio ^b   Fantozzi, Roberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,4 TRIAZOLO [4,3 A][1,8]NAPHTHYRIDINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 1; MYELOPEROXIDASE; NAPHTHYRIDINE DERIVATIVE; NF 161; NF 177; OXYGEN; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTACYCLIN; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ADHESION; CONTROLLED STUDY; DRUG INHIBITION; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; ENZYME RELEASE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INCUBATION TIME; POLYMORPHONUCLEAR CELL; UMBILICUS; VASCULAR ENDOTHELIUM;

EID: 33646367167     PISSN: 14769255     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-3-4     Document Type: Article

References (46)

1. Vane JR, Bakhle YS, Botting RM: Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998, 38:97-120.
2. Caughey GE, Cleland LG, Penglis PS, Gamble JR, James MJ: Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2. J Immunol 2001, 167:2831-2838.
3. Eligini S, Habib A, Lebret M, Creminon C, Levy-Too S, Maclouf J: Induction of cyclo-oxygenase-2 in human endothelial cells by SIN-1 in the absence of prostaglandin production. Br J Pharmacol 2001, 133:1163-1171.
4. Bouzard D, Di Cesare P, Essiz M, Jacquet JP, Ledoussal B, Remuzon P, Kessler RE, Fung-Tomc J: Fluoronaphthyridines as antibacterial agents. 4. Synthesis and structure-activity relationships of 5-substituted-6-fluoro-7-(cycloalkylamino)-1, 4-dihydro-4-oxo-1, 8-naphthyridine-3-carboxylic acids. J Med Chem 1992, 35:518-525.
5. Ferrarini PL, Manera C, Mori C, Badawneh M, Saccomanni G: Synthesis and evaluation of antimycobacterial activity of 4-phenyl-1, 8-naphthyridine derivatives. Farmaco 1998, 53:741-746.
6. Zhang SX, Bastow KF, Tachibana Y, Kuo SC, Hamel E, Mauger A, Narayanan VL, Lee KH: Antitumor agents 196 Substituted 2-thienyl-1, 8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. J Med Chem 1999, 42:4081-4087.
7. Kuroda T, Suzuki F, Tamura T, Ohmori K, Hosoe H: A novel synthesis and potent antiinflammatory activity of 4-hydroxy-2(1H)-oxo-1-phenyl-1, 8-naphthyridine-3-carboxamides. J Med Chem 1992, 35:1130-1136.
8. Ferrarini PL, Badawneh M, Franconi F, Manera C, Miceli M, Mori C, Saccomanni G: Synthesis and antiplatelet activity of some 2, 7-di(N-cycloamino)-3-phenyl-1, 8-naphthyridine derivatives. Farmaco 2001, 56:311-318.
9. Santilli AA, Scotese AC, Bauer RF, Bell SC: 2-Oxo-1, 8-naphthyridine-3-carboxylic acid derivatives with potent gastric antisecretory properties. J Med Chem 1987, 30:2270-2277.
10. Kuo SC, Tsai SY, Li HT, Wu CH, Ishii K, Nakamura H: Studies on heterocyclic compounds IX Synthesis and antiallergic activity of furo [2, 3-b] [1, 8]naphthyridine-3, 4(2H, 9H)-diones and 4H-furo[2, 3-d]pyrido[1, 2-alpha]-pyrimidine-3, 4(2H)-diones. Chem Pharm Bul 1988, 36:4403-4407.
11. Ferrarini PL, Mori C, Tellini N: Synthesis and local anesthetic activity of (E)- and (Z)-diethylaminoethyliminothers of 1, 8-naphtyridine. Farmaco 1990, 45:385-389.
12. Da Settimo A, Primofiore G, Da Settimo F, Simorini F, Barili PL, Senatore G, Martini C, Lucacchini A: Synthesis and benzodiazepine receptor activityof some 4, 5-dihydro-1H-pyrazolo[4, 3-c][1, 8]naphthyridine derivatives. Drug Des Discov 1994, 11:307-328.
13. Herzig S, Heber D, Mescheder A, Reifenstein-Herzig U, Thormann T, Verborg M, Mohr K: Pharmacological characterization of positive inotropic derivatives of 4-amino-7-methyl-1, 8-naphthyridine-3-carboxylic acid. Arzneimittelforschung 1994, 44:937-942.
14. Ferrarini PL, Mori C, Badawneh M, Calderone V, Greco R, Manera C, Martinelli A, Nieri P, Saccomanni G: Synthesis and beta-blocking activity of (R, S)-(E)-oximeethers of 2, 3-dihydro-1, 8-naphthyridine and 2, 3-dihydrothiopyrano[2, 3-b]pyridine:potential antihypertensive agents - part IX. Eur J Med Chem 2000, 35:815-826.
15. Leonard JT, Gangadhar R, Gnanasam SK, Ramachandran S, Saravanan M, Sridhar SK: Synthesis and pharmacological activities of 1, 8-naphthyridine derivatives. Biol Pharm Bull 2002, 25:798-802.
16. Roma G, Di Braccio M, Grossi G, Mattioli F, Ghia M: 1, 8-Naphthyridines IV 9-substituted N, N-dialkyl-5-(alkylamino or cycloalkylamino) [1, 2, 4]triazolo[4, 3-a][1, 8]naphthyridine-6-carboxamides, new compounds with anti-aggressive and potent anti-inflammatory activities. Eur J Med Chem 2000, 35:1021-1035.
17. Grossi G, Di Braccio M, Roma G, Ballabeni V, Tognolini M, Barocelli E: , 8-Naphthyridines v novel N-substituted 5-amino-N, N-diethyl-9-isopropyl [1, 2, 4]triazolo[4, 3-a] [1, 8]naphthyridine-6-carboxamides, as potent anti-inflammatory and/or analgesic agents completely devoid of acute gastrolesivity. Eur J Med Chem 2005, 40:1155-165.
18. Springer TA: Traffic signals for lymphocyte recirculation and leycocyte emigration: the multistep paradigm. Cell 1994, 76:301-304.
19. Takagi J, Springer TA: Integrin activation and structural rearrangement. Immunol Rev 2002, 186:141-163.
20. Avanzi GC, Gallicchio M, Bottarel F, Gammaitoni L, Cavalloni G, Buonfiglio D, Bragardo M, Bellomo G, Albano E, Fantozzi R, Garbarino G, Varnum B, Aglietta M, Saglio G, Dianzani U, Dianzani C: GAS6 inhibits granulocyte adhesion to endothelial cells. Blood 1998, 91:2334-2340.
21. Zimmerman BJ, Anderson DC, Granger DN: Neuropeptides promote neutrophil adherence to endothelial cell monolayers. Am J Physiol 1992, 263:G678-G682.
22. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
23. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins Identification by morphologic and immunologic criteria. J Clin invest 1973, 52:2745-2756.
24. Henson PM, Zanolari B, Schwartzman NA, Hong SR: Intracellular control of human neutrophil secretion I C5a-induced stimulus-specific desensitization and the effects of cytochalasin B. J Immunol 1978, 121:851-855.
25. Dianzani C, Collino M, Lombardi G, Garbarino G, Fantozzi R: Substance P increases neutrophil adhesion to human umbelical vein endothelial cells. Br J Pharmacol 2003, 139:1103-1110.
26. Dianzani C, Parrini M, Ferrara C, Fantozzi R: Effect of 4-hydroxynonenal on superoxide anion production from primed human neutrophils. Cell Biochem Funct 1996, 14:193-200.
27. Dianzani C, Brunelleschi S, Viano I, Fantozzi R: Adenosine modulation of primed human neutrophils. Eur J Pharmacol 1994, 263:223-226.
28. Fiorucci S, Santucci L, Gerli R, Brunori PM, Federici B, Ugolini B, Fabbri C, Morelli A: NSAIDs upregulate beta 2-integrin expression on human neutrophils through a calcium-dependent pathway. Aliment Pharmacol Ther 1997, 11:619-630.
29. Zimmerli W, Sansano S, Wiesenberg-Bottcher I: Influence of the anti-inflammatory compound flosulide on granulocyte function. Biochem Pharmacol 1991, 42:1913-1919.
30. Jabs T: Reactive oxygen intermediates as mediators of programmed cell death in plants and animals. Biochem Pharmacol 1999, 57:231-245.
31. Dalton TP, Shertzer HG, Puga A: Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol Toxicol 1999, 39:67-101.
32. Lucchesi BR: Modulation of leukocyte-mediated myocardial reperfusion injury. Ann Rev Physiol 1990, 52:561-576.
33. Li H, Cybulski MI, Gimbrone MA, Libby P: An atherogenic diet rapidly induce VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Atherioscler Thromb 1993, 13:197-204.
34. Jang Y, Lincoff AM, Plow EF, Topol EJ: Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol 1994, 24:1591-1601.
35. Tonnesen MG, Smedly LA, Henson PM: Neutrophil-endothelial cell interactions Modulation of neutrophils adhesiveness induced by complement fragments C5a and C5a des arg and formyl-methionyl-leucyl-phenylalanine in vitro. J Clin Invest 1984, 74:1581-1592.
36. Zimmerman GA, McIntire TM, Prescott SM: Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Invest 1985, 76:2235-2246.
37. Choi JS, Choi YJ, Park SH, Kang JS, Kang YH: Flavones mitigate tumor necrosis factor-alpha-induced adhesion molecule upregulation in cultured human endothelial cells: role of nuclear factor-kappa B. J Nutr 2004, 134:1013-1019.
38. Yang YY, Hu CJ, Chang SM, Tai TY, Leu SJ: Aspirin inhibits monocyte chemoattractant protein-1 and interleukin-8 expression in TNF-alpha stimulated human umbilical vein endothelial cells. Atherosclerosis 2004, 174:207-213.
39. Breviario F, Bertocchi F, Dejana E, Bussolino F: IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells Role of platelet-activating factor. J Immunol 1988, 141:3391-3397.
40. Hill ME, Bird IN, Daniels RH, Elmore MA, Finnen MJ: Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but not transmigration across IL-1 beta-treated endothelial monolayers. J Immunol 1994, 153:3673-3683.
41. Macconi D, Foppolo M, Paris S, Noris M, Aiello S, Remuzzi G, Remuzzi A: PAF mediates neutrophil adhesion to thrombin or TNF-stimulated endothelial cells under shear stress. Am J Physiol 1995, 269:C42-C47.
42. Nixon JB, McPhail LC: Protein kinase C (PKC) isoforms translocate to Triton-insoluble fractions in stimulated human neutrophils: correlation of conventional PKC with activation of NADPH oxidase. J Immunol 1999, 163:4574-4582.
43. Itoh M, Omi H, Okouchi M, Imaeda K, Shimizu M, Fukutomi T, Okayama N: The mechanisms of inhibitory actions of gliclazide on neutrophils-endothelial cells adhesion and surface expression of endothelial adhesion molecules mediated by a high glucose concentration. J Diabetes Complication 2003, 17:22-26.
44. Altieri DC, Agbanyo FR, Plescia J, Ginsberg MH, Edgington TS, Plow EFJ: A unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1(CD11b/CD18). J Biol Chem 1990, 265:12119-12122.
45. Ulbrich H, Eriksson EE, Lindbom L: Leucocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends Pharmacol Sci 2003, 24:640-647.
46. Berton G, Lowell CA: Integrin signaling in neutrophils and macrophages. Cell Signal 1999, 11:621-635.